Lightwave Logic (LWLG) risk factors, FY2024 10-K

Lightwave Logic's FY2024 10-K, filed Mar 18, 2025, lists 41 risk factors. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
410 groups
Section length
10k wordsItem 1A

Lightwave Logic's biggest risks in the FY2024 10-K

  • Lightwave Logic relies on ongoing research of electro-optic polymer materials, with funding projected to last only through April 2026.
  • The company faces high capital needs, lengthy commercial qualification cycles, and intense competition from established photonics technologies.

The risks most specific to Lightwave Logic

  • We have incurred substantial operating losses since our inception and will continue to incur substantial operating losses for the foreseeable future

    We incurred a net loss of $22,535,041 for the year ended December 31, 2024, and $21,038,032 for 2023, and will continue to incur substantial operating losses.

  • We will require additional capital to continue to fund our operations and if we do not obtain additional capital, we may be required to substantially limit our operations

    We have sufficient funds to finance our operations only through April 2026 and will need to obtain additional future financing.

  • We are entering new markets, and if we fail to accurately predict growth in these new markets, we may suffer substantial losses

    We are initially targeting fiber optic data communications and telecommunications markets, specifically ultra-high bandwidth optical connections inside and between datacenters and AI clusters.

  • Our potential customers require our products to undergo a lengthy and expensive qualification process, which does not assure product sales

    Potential customers require our products to undergo extensive qualification processes lasting several months or more without assuring any sales.

  • Obtaining a sales contract with a potential customer does not guarantee that a potential customer will not decide to cancel or change its product plans, which could cause us to generate no revenue from a product and adversely affect our results of operations

    It could take 12 to 24 months from early engagement by our sales team to actual product sales, risking customer cancellations.

  • One of our significant target markets is the telecommunications market, which historically has not accepted polymer modulators

    The telecommunications market has historically not accepted polymer modulators despite Telcordia-based specifications.

  • Another of our significant target markets is the data communications (datacenter and/or high performance computing) market, which may be subject to heavy competition from other PIC based technologies such as silicon photonics and Indium Phosphide

    Our data communications market is subject to heavy competition from other PIC-based technologies such as silicon photonics and Indium Phosphide.

  • The loss of certain of our key personnel, or any inability to attract and retain additional personnel, could impair our ability to attain our business objectives

    Our future success depends on key executives Yves LeMaitre, Thomas E. Zelibor, and James S. Marcelli.

  • We conduct significantly all of our research and development activities at our Englewood, CO facility, and circumstances beyond our control may result in considerable business interruptions

    We conduct significantly all of our research and development activities at a single facility in Englewood, Colorado, making us vulnerable to natural disasters and interruptions.

  • The trading price of our common stock has been, and may continue to be, volatile, and the value of our common stock may decline. This volatility, as well as general market conditions, may cause our stock price to fluctuate greatly and even potentially expose us to litigation

    During the past 52 weeks, our common stock share price ranged from a low of $1.00 to a high of $4.82.

All 41 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01We have incurred substantial operating losses since our inception and will continue to incur substantial operating losses for the foreseeable future
  2. 02We are subject to the risks frequently experienced by early-stage companies
  3. 03Our failure to effectively manage our growth and effectively transition from our focus on research and development activities to commercial operations could harm our business
  4. 04We will require additional capital to continue to fund our operations and if we do not obtain additional capital, we may be required to substantially limit our operations
  5. 05We are entering new markets, and if we fail to accurately predict growth in these new markets, we may suffer substantial losses
  6. 06Our plan to develop relationships with strategic partners may not be successful
  7. 07The failure to establish and maintain collaborative relationships may have a materially adverse affect on our business
  8. 08We may participate in joint ventures that expose us to operational and financial risk
  9. 09If we fail to develop and introduce new or enhanced products on a timely basis, our ability to attract and retain customers could be impaired and our competitive position could be harmed
  10. 10Our future growth will suffer if we do not achieve sufficient market acceptance of our organic nonlinear optical materials
  11. 11Our potential customers require our products to undergo a lengthy and expensive qualification process, which does not assure product sales
  12. 12Obtaining a sales contract with a potential customer does not guarantee that a potential customer will not decide to cancel or change its product plans, which could cause us to generate no revenue from a product and adversely affect our results of operations
  13. 13Many of our products will have long sales cycles, which may cause us to expend resources without an acceptable financial return and which makes it difficult to plan our expenses and forecast our revenue
  14. 14Successful commercialization of our current and future products will require us to maintain a high level of technical expertise
  15. 15One of our significant target markets is the telecommunications market, which historically has not accepted polymer modulators
  16. 16Another of our significant target markets is the data communications (datacenter and/or high performance computing) market, which may be subject to heavy competition from other PIC based technologies such as silicon photonics and Indium Phosphide
  17. 17Our inability to successfully acquire and integrate other businesses, assets, products or technologies could harm our business and cause us to fail at achieving our anticipated growth
  18. 18We may incur debt in the future that might be secured with our intellectual property as collateral, which could subject our Company to the risk of loss of all of our intellectual property
  19. 19Our failure to compete successfully could harm our business
  20. 20We may be unable to obtain effective intellectual property protection for our products and technology
  21. 21We may be subject to patent infringement claims, which could result in substantial costs and liability and prevent us from selling our products
  22. 22Our technology may be subject to government rights
  23. 23The loss of certain of our key personnel, or any inability to attract and retain additional personnel, could impair our ability to attain our business objectives
  24. 24If we fail to develop and maintain the quality of our manufacturing integration and design processes, our operating results would be harmed
  25. 25The complexity of our organic nonlinear optical materials may lead to errors, defects and bugs, which could result in the necessity to redesign materials and could negatively impact our reputation with customers
  26. 26If we decide to make commercial quantities of products at our facilities, we will be required to make significant capital expenditures to increase capacity
  27. 27We may not be able to manufacture products at competitive prices
  28. 28We may be unable to export our products or technology to other countries, convey information about our technology to citizens of other countries or sell certain products commercially, if the products or technology are subject to United States export or other regulations
  29. 29We are subject to regulatory compliance related to our operations
  30. 30We may incur liability arising from the use of hazardous materials
  31. 31We conduct significantly all of our research and development activities at our Englewood, CO facility, and circumstances beyond our control may result in considerable business interruptions
  32. 32We could be negatively affected as a result of a proxy contest and the actions of activist stockholders
  33. 33The requirements of being a public company are a strain on our systems and resources, are a diversion to management’s attention and are costly
  34. 34If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired
  35. 35The exercise of options and warrants and other issuances of shares of common stock or securities convertible into common stock will dilute your interest
  36. 36The trading price of our common stock has been, and may continue to be, volatile, and the value of our common stock may decline. This volatility, as well as general market conditions, may cause our stock price to fluctuate greatly and even potentially expose us to litigation
  37. 37A sale of a substantial number of shares of our common stock may cause the price of our common stock to decline and may impair our ability to raise capital in the future
  38. 38Our common stock will be subject to potential delisting if we do not maintain the listing requirements of the Nasdaq Capital Market
  39. 39If securities or industry analysts do not publish research or reports about our business, or if they change their recommendations regarding our stock adversely, our stock price and trading volume could decline
  40. 40Our board of directors has the authority, without stockholder approval, to issue preferred stock with terms that may not be beneficial to existing common stockholders and with the ability to affect adversely stockholder voting power and perpetuate their control over us
  41. 41Our articles of incorporation and amended and restated bylaws, and certain provisions of Nevada corporate law, as well as certain of our contracts, contain provisions that could delay or prevent a change in control even if the change in control would be beneficial to our stockholders

Other Lightwave Logic 10-Ks

  • FY2025 10-K risk factors
    39 risks2 dropped4 reworded

    Lightwave Logic updated key executive names, extended its cash runway horizon, and reported a lower net loss for 2025.

    Filed Mar 20, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.